A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers

NCT03250052 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: (fimasartan or linagliptin) x 7days
DRUG: (fimasartan and linagliptin) x 7days

Sponsor

Boryung Pharmaceutical Co., Ltd